Cell Replacement Therapy: Differentiate patient or healthy donor-derived iPSCs into target cells (such as dopaminergic neurons for Parkinson's disease, retinal cells for eye diseases), and transplant them back into the body after strict quality control to repair damaged tissue functions.Gene Correction Therapy: For genetic diseases, gene editing technology can be used to correct pathogenic mutations at the iPSC stage, and then differentiate into healthy cells for transplantation to achieve radical treatment.What We Provide: Clinical-grade iPSC line establishment and storage, immune-matched iPSC bank, differentiation and preparation services for specific therapeutic cells (such as mesenchymal stem cells/iMSC, neural progenitor cells, etc.).